Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.
about
Different Subsets of T Cells, Memory, Effector Functions, and CAR-T ImmunotherapyPhase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers.Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma.Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells.The growing world of CAR T cell trials: a systematic review.Driving better and safer HER2-specific CARs for cancer therapy.T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy.Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth.Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types.Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells.Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells.Viroimmunotherapy for Colorectal Cancer: Clinical Studies.
P2860
Q26752955-08912FC1-CDCA-4557-AC63-6E6DD2F22D92Q38677904-08A00924-E975-41AF-8877-85EE5383AA0BQ38782345-36D1F954-F965-4A1E-98FC-EAC81145E91BQ38787449-D8201893-EF5D-40A9-890B-942B050C5F88Q38950791-A3163FF6-0BC2-46E2-B84E-3EB9FC91E50AQ41835996-1618B577-ED56-4F4B-BCE6-8BDB9FD4AF15Q42333881-C2A24680-D40B-4ECE-B810-70719DF70B71Q45857417-FAC49052-E8FC-4198-8130-7F0287603B72Q47121255-6EF61294-EBDB-4D3A-B11C-836BF8AD43D1Q47159409-82990E6A-A78B-47F3-8E54-C58F6CBEA63CQ49210694-683EFCE0-9E73-46CC-B590-9B895EEBD848Q50315378-6C724DA1-F1C4-46AE-934D-0CD12B8E4F19Q55085114-10020418-93B2-4175-9375-577DE9955D95
P2860
Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.
@en
type
label
Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.
@en
prefLabel
Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.
@en
P2860
P356
P1433
P1476
Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors.
@en
P2093
Hinrich Abken
P2860
P304
P356
10.2217/IMT.15.15
P577
2015-06-01T00:00:00Z